ClinicalTrials.gov
public full text
Public Domain
Topical Composition Therapy (2013-MCN-333) for the Treatment of Melasma
The purpose of this research study is to gather information on the effectiveness and tolerability of a novel composition of existing U.S. Food and Drug Administration (FDA) approved topical medications for the treatment of moderate to severe melasma.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Treatment of Melasma With Glycolic Acid-Salicylic Acid Peel Versus Glycolic Acid Peel#1197253
- Study Evaluating the Efficacy of DOSE Formulations in Treating Melasma and Cutaneous Signs of Aging#864725
- Study of Light Treatment and Laser Treatment for Melasma#1371416
- Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma#843942
- Azelaic Acid Versus Hydroquinone in Melasma#880551
Record · ID 1213281
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive